The Food and Drug Administration is now investigating why hundreds of consumers have reported becoming ill after eating Lucky Charms cereal.
At least 139 consumers across the country reported they vomited and had...
A COVID-19 investigational vaccine, developed by City of Hope scientists and now licensed to GeoVax Labs Inc., produced a robust neutralizing antibody and T cell (an immune cell) response against SARS-CoV-2 with no significant side effects in...
Researchers at the UBC Faculty of Medicine are the first in the world to conduct a molecular-level structural analysis of the Omicron variant spike protein.
The analysis—done at near-atomic resolution using a cryo-electron microscope—reveals...
Rare disease therapy developer, Immusoft, has signed a licensing agreement with Takeda Pharmaceutical with a total potential value of more than $900 million, to discover, develop and commercialize transformative cell therapies in rare inherited metabolic disorders with...
The World Health Organization on Wednesday endorsed the malaria vaccine Mosquirix, the first step in a process that should lead to wide distribution in poor countries. To have a malaria vaccine that is safe, moderately effective and...
The Prix Galien Awards Committee announced that six world-leading biopharma companies responsible for the development of COVID-19 vaccines and therapeutics will jointly receive the 2021 Roy Vagelos Pro Bono Humanum Award for Global Health Equity at the...
According to media reports, the Food and Drug Administration is pushing to approve Pfizer-BioNTech’s two-dose Covid-19 vaccine by early next week, further expediting an earlier timeline for licensing the shot, according to people familiar with the agency’s...
Amgen Inc received approval from the U.S. Food and Drug Administration for its cancer drug, Lumakras (sotorasib) as the first treatment for adult patients with non-small cell lung cancer whose tumors have a specific type of genetic...
Bristol Myers Squibb (BMS) will gain the global rights to Agenus’ investigational cancer drug, AGEN1777, in a deal worth up to $1.38 billion.
Under the licensing agreement, BMS will spearhead development and commercialization of...
Johnson & Johnson COVID-19 single-shot vaccine will resume for all adults aged 18 years and older in the U.S., under Emergency Use Authorization, following a decision from the United States Centers for Disease Control (CDC) and Food...
Results from Zillow's Consumer Housing Trends Report show renters of color typically submit more applications — and pay more in application fees — before they secure...
A COVID-19 investigational vaccine, developed by City of Hope scientists and now licensed to GeoVax Labs Inc., produced a robust neutralizing antibody...
